Enveric Biosciences Inc. Common Stock (ENVB)
Stock · NASDAQ · Health Care
$1.39as of 10/16/2026
Price chart
Active signals
ENVB Signal Track Record
How signals performed across all stocks →What ENVB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 26 | -10.9% | 27% | June 9, 2026 |
| Bollinger Band Breakout | 16 | -24.6% | 19% | September 17, 2026 |
| Volume Spike | 15 | -13.8% | 27% | September 14, 2026 |
| Any 20-session window (baseline) | -12.0% | 29% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ENVB
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indole…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 5
- Website
- www.enveric.com/
Fundamentals
- 1-day range
- $1.35$1.44
- Market cap
- $6.28M
- P/E (trailing)
- —
- P/E (forward)
- -0.99
- EPS (trailing)
- $-11.15
- Dividend yield
- —
- Beta
- 1.26
- Avg. volume
- 101.4K
- Ex-dividend date
- April 23, 2008
- Dividend pay date
- November 25, 2019
How Enveric Biosciences Inc. Common Stock Makes Money
Where the revenue actually goes — FY2019 annual results
Source: 10-K filed Mar 25, 2020 · via SEC EDGAR / Finnhub
Enveric Biosciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ENVBEnveric Biosciences Inc. Common Stock$1.38▼ 0.72%Market cap $6.28MP/E —$1.17$13.25
- ACXPAcurx Pharmaceuticals Inc. Common Stock$1.1▼ 5.98%Market cap $6.27MP/E —$1.15$7.87
- HCWBHCW Biologics Inc. Common Stock$1.24▲ 0.81%Market cap $6.19MP/E —$1.14$27.3
- APVOAptevo Therapeutics Inc. Common Stock$1.62▼ 4.71%Market cap $6.18MP/E 0.00$1.37$30.06
- GELSGelteq Limited Ordinary Shares$0.446▲ 3.48%Market cap $6.15MP/E —$0.387$2.01
- PULMPulmatrix Inc. Common Stock$1.36▼ 3.55%Market cap $6.06MP/E —$1.16$5.24
- XBIOXenetic Biosciences Inc. Common Stock$1.99▼ 1.00%Market cap $6.53MP/E —$1.87$5.28
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ENVB Enveric Biosciences Inc. Common Stock | $6.28M | — | $1.38 | ▼ 0.72% | $1.17$13.25 |
| ACXP Acurx Pharmaceuticals Inc. Common Stock | $6.27M | — | $1.1 | ▼ 5.98% | $1.15$7.87 |
| HCWB HCW Biologics Inc. Common Stock | $6.19M | — | $1.24 | ▲ 0.81% | $1.14$27.3 |
| APVO Aptevo Therapeutics Inc. Common Stock | $6.18M | 0.00 | $1.62 | ▼ 4.71% | $1.37$30.06 |
| GELS Gelteq Limited Ordinary Shares | $6.15M | — | $0.446 | ▲ 3.48% | $0.387$2.01 |
| PULM Pulmatrix Inc. Common Stock | $6.06M | — | $1.36 | ▼ 3.55% | $1.16$5.24 |
| XBIO Xenetic Biosciences Inc. Common Stock | $6.53M | — | $1.99 | ▼ 1.00% | $1.87$5.28 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 SeriesYahoo · 9/15/2026
- Enveric Biosciences Receives U.S. Patent Office Notice Of Allowance For An Application Covering Novel Compounds Within Its EVM401 Series Of Drug CandidatesBenzinga · 9/15/2026
Insider Activity
Insider Actions →- DeWitt Sheila · June 1, 2026 · Grant18.5K
- Coveney Kevin Michael · June 1, 2026 · Grant133.3K
- Facchini Peter J. · June 1, 2026 · Grant25.0K
- Tucker Joseph Edward · June 1, 2026 · Grant201.1K
- Kegler George A. · June 1, 2026 · Grant18.5K
- Schabacker Marcus · June 1, 2026 · Grant18.5K
- PASQUALONE FRANK · June 1, 2026 · Grant18.5K
- WEBB MICHAEL D · June 1, 2026 · Grant18.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 55.0K
- Total value held
- $106.6K
- Institutional holders
- 11
- Unknown32.1K
- Unknown17.0K
- Unknown3.6K
- Unknown1.1K
- Unknown1.0K
- Unknown83
- Unknown51
- Unknown1
- Unknown1
- Unknown1
See the full, filterable feed with live charts on the MarketWall dashboard.